Moritz Gerstung, PhD^1,2*, Elli Papaemmanuil, PhD^2,3*, Inigo Martincorena, PhD^2*, Lars Bullinger, MD⁴, Verena I. Gaidzik, MD^4*, Peter Paschka, MD⁴, Michael Heuser, M.D.⁵, Felicitas Thol, MD⁶, Niccolo Bolli, mD, PhD^2,7*, Peter Ganly^8*, Arnold Ganser, M.D.⁶, Ultan McDermott, MD, PhD^2*, Michael R Stratton, MD, PhD^2*, Konstanze Döhner, MD⁴, Hartmut Döhner, Prof. Dr.⁴, Richard F. Schlenk, MD⁴ and Peter J Campbell, MD, PhD^9*

¹European Bioinformatics Institute EMBL-EBI, Cambridge, United Kingdom
²Wellcome Trust Sanger Institute, Cambridge, United Kingdom
³Memorial Sloan Kettering Cancer Center, New York, NY
⁴Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany
⁵Hematology, Hemostasis, Oncology and SCT, Hannover Medical School, Hannover, Germany
⁶Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany
⁷Division of Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori, University of Milano, Milan, Italy
⁸Christchurch Hospital, Christchurch, New Zealand
⁹Cancer genome Project, Wellcome Trust Sanger Institute, Cambridge, United Kingdom

Aziz Nazha, MD¹, Ahmad Zarzour, MD², Tomas Radivoyevitch, PhD^3*, Hetty E. Carraway, MD, MBA⁴, Jennifer S. Carew, Ph.D.⁵, Cassandra M Hirsch^6*, Kassy E Kneen^7*, Bartlomiej Przychodzen, MSc^8*, Bhumika J. Patel^5*, Michael Clemente, MS^9*, Srinivasa R. Sanikommu, MBBS¹⁰, Matt Kalaycio, MD¹¹, Jaroslaw P. Maciejewski, MD, Ph.D.⁵ and Mikkael A. Sekeres, MD, MS⁴

¹Leukemia Program, Department of Hematology and Oncology, Cleveland Clinic, Taussig Cancer Institute, Cleveland, OH
²Leukemia Program, Cleveland Clinic - Taussig Cancer Institute, Cleveland, OH
³Department of Hematology and Medical Oncology, Cleveland Clinic, Cleveland, OH
⁴Leukemia Program, Cleveland Clinic, Cleveland, OH
⁵Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
⁶Department of Translational Hematology and Oncology Research, Taussing Cancer Institute, Cleveland Clinic, Cleveland, OH
⁷Department of Translational Hematology, Cleveland Clinic, Taussig Cancer Institute, Cleveland
⁸Haematological Medicine, Department of Translational hematology and Oncology Research, Taussing Cancer Institute, Cleveland Clinic, London, United Kingdom
⁹Experimental Hematology and Hematopoiesis, Cleveland Clinic Foundation, Cleveland, OH
¹⁰Cleveland Clinic Taussing Cancer Institute, Cleveland, OH
¹¹Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH

Katherine Tarlock, MD¹, M. Eva Hansen^2*, Tiffany Hylkema^2*, Rhonda Ries, MA^3*, Jason E. Farrar, M.D.⁴, Jaime Guidry Auvil^5*, Daniela S. Gerhard, PhD^6*, Malcolm A. Smith, MD, PhD^7*, Tanja M. Davidsen, PhD^6*, Patee Gesuwan^6*, Leandro C. Hermida^6*, Marco A Marra, PhD⁸, Andrew J. Mungall, PhD⁹, Karen Mungall, PhD^9*, Yussanne Ma^9*, Stuart Zong^9*, William Long, PhD^9*, Titus Boggon, PhD^10*, Todd A. Alonzo, PhD¹¹, E. Anders Kolb, MD¹², Alan S. Gamis, MD, MPH¹³ and Soheil Meshinchi, MD, PhD³

¹Fred Hutchinson Cancer Research Center, Seattle, WA
²Fred Hutchsinson Cancer Research Center, Seattle, WA
³Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA
⁴Department of Pediatics/Hematology Oncology Section, University of Arkansas for Medical Sciences, Little Rock, AR
⁵National Cancer Institute, Bethesda
⁶Office of Cancer Genomics, National Cancer Institute, Bethesda, MD
⁷NCI/Ctep/Cib, National Institutes of Health, Bethesda, MD
⁸Canada’s Michael Smith Genome Sciences Centre, British Columbia Cancer Agency, Vancouver, BC, Canada
⁹Michael Smith Genome Sciences Centre, British Columbia Cancer Agency, Vancouver, BC, Canada
¹⁰Pharmacology, Yale Univ. School of Medicine, New Haven, CT
¹¹Keck School of Medicine, University of Southern California, Los Angeles, CA
¹²Nemours Center for Cancer and Blood Disorders, Alfred I. duPont Hospital for Children, Wilmington, DE
¹³Division of Hematology/Oncology/Bone Marrow Transplantation, Children's Mercy Hospitals and Clinics, Kansas City, MO

Fiona Brown, PhD^1*, Eric Still^1*, Paolo Cifani, PhD^1*, Scott Ficarro, PhD^2*, Gayle Pouliot, MD, PhD³, Esther Drill, PhD^1*, Mithat Gonen, PhD^4*, Jie He, PhD^5*, Sohail Balasubramanian, M.S.^5*, Shan Zhong, PhD^5*, Dean Pavlick^5*, Bahar Yilmazel^5*, Andrei V. Krivtsov, PhD^6*, Todd A. Alonzo, PhD⁷, Soheil Meshinchi, MD, PhD⁸, Steven M. Kornblau, MD⁹, Richard M. Stone, MD¹⁰, Guido Marcucci, MD¹¹, John C. Byrd, MD¹², Ross L. Levine, MD¹³, Scott A. Armstrong, MD, PhD¹, Nathanael Gray, PhD^14*, Jarrod Marto, PhD^2* and Alex Kentsis, MD, PhD¹³

¹Memorial Sloan-Kettering Cancer Center, New York, NY
²Dana-Farber Cancer Institute, Boston, MA
³Children's Hospital Boston, Boston, MA
⁴Statistics, Memorial Sloan Kettering Cancer Center, New York, NY
⁵Foundation Medicine, Inc., Cambridge, MA
⁶Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY
⁷Children's Oncology Group, Monrovia, CA
⁸Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA
⁹Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
¹⁰Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
¹¹The Ohio State University Comprehensive Cancer Center, Columbus, OH
¹²Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH
¹³Memorial Sloan Kettering Cancer Center, New York, NY
¹⁴Dept of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA

Satoshi Saida, MD, PhD^1,2*, Masahiro Nakamura, MD, PhD^3*, Tsutomu Toki, PhD⁴, Yoko Nishinaka-Arai, Ph.D.^5*, Kiminori Terui, MD, PhD^4*, Kenichi Yoshida, MD, Ph.D.^6*, Seishi Ogawa, MD, Ph.D.⁶, Tatsutoshi Nakahata, MD, PhD^2,5, Toshio Heike, MD, PhD^1,2*, Ken-ichiro Watanabe, MD, PhD^1,2,7*, Akira Watanabe, PhD^2,3* and Etsuro Ito, MD, PhD^2,4

¹Department of Pediatrics, Graduate School of Medicine Kyoto University, Kyoto, Japan
²AMED-CREST, Japan Agency for Medical Research and Development, 1-7-1 Otemachi, Chiyoda-ku, Tokyo 100-0004, Tokyo, Japan
³Department of Life Science Frontiers, Center for iPS Cell Research and Application (CiRA), Kyoto University, Kyoto, Japan
⁴Department of Pediatrics, Hirosaki University Graduate School of Medicine, Hirosaki, Japan
⁵Clinical Application Department, Center for iPS Cell Research and Application (CiRA), Kyoto University, Kyoto, Japan
⁶Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan
⁷Division of Hematology and Oncology, Shizuoka Children's Hospital, Shizuoka, Japan

Francois Vergez, DVM, PhD^1,2*, Sarah Bertoli, MD, PhD^3*, Marina Bousquet, PhD^3*, Marie-Laure Nicolau-Travers^4*, Michael Peres, PharmD^2*, Estelle Saland^5*, Françoise Huguet, MD^6*, Isabelle Luquet, MD^7*, Veronique Mansat-de Mas, PharmD, PhD^2*, Cecile Demur, MD^8*, Eric Delabesse, MD, PhD^2*, Gwenn Danet-Desnoyers, PhD¹, Jean-Emmanuel Sarry, PhD^5* and Christian Récher, MD PhD⁹

¹Division of Hematology and Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
²Institut Universitaire du Cancer, University Hospital of Toulouse, Toulouse, France
³INSERM, Cancer Research Center of Toulouse, Toulouse, France
⁴Institut Universitaire du Cancer, Toulouse, France
⁵INSERM, CRCT, Toulouse, France
⁶Hematology department, Institut universitaire du cancer de Toulouse, Toulouse, France
⁷CHU Toulouse, Toulouse, France
⁸Hopital PURPAN, Toulouse, France
⁹Institut Universitaire du Cancer de Toulouse Oncopole, Toulouse, France